These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 15310169)

  • 21. Editorial commentary: A rare event: a measles outbreak in a population with high 2-dose measles vaccine coverage.
    Seward JF; Orenstein WA
    Clin Infect Dis; 2012 Aug; 55(3):403-5. PubMed ID: 22543021
    [No Abstract]   [Full Text] [Related]  

  • 22. Immune responses to measles and measles vaccine: challenges for measles control.
    Moss WJ; Polack FP
    Viral Immunol; 2001; 14(4):297-309. PubMed ID: 11792060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An increasing, potentially measles-susceptible population over time after vaccination in Korea.
    Kang HJ; Han YW; Kim SJ; Kim YJ; Kim AR; Kim JA; Jung HD; Eom HE; Park O; Kim SS
    Vaccine; 2017 Jul; 35(33):4126-4132. PubMed ID: 28669617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Persistence of vaccine-induced antibody to measles 26-33 years after vaccination.
    Dine MS; Hutchins SS; Thomas A; Williams I; Bellini WJ; Redd SC
    J Infect Dis; 2004 May; 189 Suppl 1():S123-30. PubMed ID: 15106101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Investigation of the effectiveness of measles vaccination in children in Kenya.
    Bell TM; Tukei PM; Ademba GR; Mbugua FM; Gathara GW; Magana JM; Kinyanjui P; Muli J; Hazlett DT; Alwar JE
    J Hyg (Lond); 1985 Dec; 95(3):695-702. PubMed ID: 3912434
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estimation of measles vaccination coverage using the Lot Quality Assurance Sampling (LQAS) method--Tamilnadu, India, 2002-2003.
    Sivasankaran S; Manickam P; Ramakrishnan R; Hutin Y; Gupte MD;
    MMWR Suppl; 2006 Apr; 55(1):16-9. PubMed ID: 16645577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Barriers encountered during the implementation of a policy guideline on the vaccination of health care workers during the 2013-2014 measles outbreak in the Netherlands: a qualitative study.
    Borggreve SJ; Timen A
    BMC Res Notes; 2015 Dec; 8():780. PubMed ID: 26667824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measles antibody levels after vaccination with Edmonston-Zagreb and Schwarz measles vaccine at 9 months or at 9 and 18 months of age: a serological study within a randomised trial of different measles vaccines.
    Martins C; Garly ML; Bale C; Rodrigues A; Benn CS; Whittle H; Aaby P
    Vaccine; 2013 Nov; 31(48):5766-71. PubMed ID: 23994379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of subclinical infection on maintaining immunity against measles in vaccinated children in West Africa.
    Whittle HC; Aaby P; Samb B; Jensen H; Bennett J; Simondon F
    Lancet; 1999 Jan; 353(9147):98-102. PubMed ID: 10023894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibody response to measles immunization in rural Ghanaian infants.
    Sakatoku H; Nakano T; Arai S; Afari EA
    J Trop Pediatr; 1994 Oct; 40(5):291-3. PubMed ID: 7807624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Possibilities of measles vaccination in children with counterindications and duration of preservation of postvaccinal immunity].
    Piriev GG; Liashchenko VA
    Pediatriia; 1990; (12):27-30. PubMed ID: 2075059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measles, immune suppression and vaccination: direct and indirect nonspecific vaccine benefits.
    Mina MJ
    J Infect; 2017 Jun; 74 Suppl 1():S10-S17. PubMed ID: 28646947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Measles outbreak in western Sydney. Vaccine failure or failure to vaccinate?
    McDonnell LF; Jorm LR; Patel MS
    Med J Aust; 1995 May; 162(9):471-5. PubMed ID: 7746203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of heterogeneity in uptake of the measles, mumps, and rubella vaccine on the potential for outbreaks of measles: a modelling study.
    Glasser JW; Feng Z; Omer SB; Smith PJ; Rodewald LE
    Lancet Infect Dis; 2016 May; 16(5):599-605. PubMed ID: 26852723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modelling the impact of vaccination strategies.
    Wallinga J
    Neth J Med; 2002 Aug; 60(7 Suppl):67-75; discussion 76-7. PubMed ID: 12430593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Measles control in Kinshasa, Zaire improved with high coverage and use of medium titre Edmonston Zagreb vaccine at age 6 months.
    Cutts FT; Othepa O; Vernon AA; Nyandu B; Markowitz LE; Deforest A; Wilkins K; Okwo B
    Int J Epidemiol; 1994 Jun; 23(3):624-31. PubMed ID: 7960392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Immunological reactivity of children vaccinated with a live measles vaccine].
    Bolotovskiĭ VM; Titova NS; Zakharova TR; Vorotyntseva NV; Mushkova EM
    Vopr Virusol; 1983; 28(5):588-90. PubMed ID: 6659474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Measles outbreak in a northern Pakistani village: epidemiology and vaccine effectiveness.
    Murray M; Rasmussen Z
    Am J Epidemiol; 2000 Apr; 151(8):811-9. PubMed ID: 10965978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modelling vaccination programmes against measles in Taiwan.
    Chen SC; Chang CF; Jou LJ; Liao CM
    Epidemiol Infect; 2007 Jul; 135(5):775-86. PubMed ID: 17064459
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Measles epidemic in Romania, 1996-1998: assessment of vaccine effectiveness by case-control and cohort studies.
    Hennessey KA; Ion-Nedelcu N; Craciun MD; Toma F; Wattigney W; Strebel PM
    Am J Epidemiol; 1999 Dec; 150(11):1250-7. PubMed ID: 10588086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.